Cell cycle, CDKs and cancer: a changing paradigm

Cited by (1,005)

Items 601–700 of 1,005

1. CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors
   Meiyang Xi, Tingkai Chen, Chunlei Wu, Xiaozhong Gao, Yonghua Wu, Xiang Luo, Kui Du, Lemao Yu, Tao Cai, Runpu Shen et al. · 2018 · European Journal of Medicinal Chemistry
2. Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma
   Sarah M. Bronner, Karl A. Merrick, Jeremy M. Murray, Laurent Salphati, John G. Moffat, Jodie Pang, Christopher J. Sneeringer, Nicholas Dompe, Patrick Cyr, Hans E. Purkey et al. · 2019 · Bioorganic & Medicinal Chemistry Letters
3. Novel Targeting of Transcription and Metabolism in Glioblastoma
   Yuting Su, Robert E. Chen, Herui Wang, Hua Song, Qi Zhang, Li‐Yuan Chen, Hallie Lappin, Gabriel Vasconcelos, Adrian Lita, Dragan Maric et al. · 2017 · Clinical Cancer Research
4. The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies
   Giuseppina Augimeri, Cinzia Giordano, Luca Gelsomino, Pierluigi Plastina, Ines Barone, Stefania Catalano, Sebastiano Andò, Daniela Bonofiglio · 2020 · Cancers
5. Analysis of Gene Expression Profiling in Meningioma: Deregulated Signaling Pathways Associated with Meningioma and EGFL6 Overexpression in Benign Meningioma Tissue and Serum
   Xuanchun Wang, Ye Gong, Daijun Wang, Qing Mei Xie, Mingzhe Zheng, Yu Zhou, Qin Li, Zhen Hua Yang, Hailiang Tang, Yiming Li et al. · 2012 · PLoS ONE
6. Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation
   M. L. Sangwan, Sean R. McCurdy, Izhar Livne‐Bar, Mohammad Abd El-Rahman Ahmad, Jeffrey L. Wrana, Danian Chen, Rod Bremner · 2012 · Oncogene
7. Murine Airway Luminal Antituberculosis Memory CD8 T Cells by Mucosal Immunization Are Maintained Via Antigen-Driven In Situ Proliferation, Independent of Peripheral T Cell Recruitment
   Mangalakumari Jeyanathan, Jingyu Mu, Sarah M. McCormick, Daniela Damjanovic, Cherrie-Lee N. Small, Christopher R. Shaler, Kapilan Kugathasan, Zhou Xing · 2009 · American Journal of Respiratory and Critical Care Medicine
8. Chromobox Homolog 4 Is Correlated with Prognosis and Tumor Cell Growth in Hepatocellular Carcinoma
   Boqing Wang, Jianjun Tang, Dan Liao, Gang Wang, Meifang Zhang, Yi Sang, Jingying Cao, Yuanzhong Wu, Ruhua Zhang, Shengping Li et al. · 2013 · Annals of Surgical Oncology
9. Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor Efficacy
   Clara Albanese, Rachele Alzani, Nadia Amboldi, Nilla Roberta Avanzi, Dario Ballinari, Maria Gabriella Brasca, Claudio Festuccia, Francesco Fiorentini, Giuseppe Locatelli, Wilma Pastori et al. · 2010 · Molecular Cancer Therapeutics
10. Morphological Profiling Identifies a Common Mode of Action for Small Molecules with Different Targets
    Tabea Schneidewind, Alexandra Brause, Axel Pahl, Annina Burhop, Tom Mejuch, Sonja Sievers, Herbert Waldmann, Slava Ziegler · 2020 · ChemBioChem
11. Targeting Phosphatases and Kinases: How to Checkmate Cancer
    Alice Turdo, Caterina D’Accardo, Antonino Glaviano, Gaetana Porcelli, Cristina Colarossi, Lorenzo Colarossi, Marzia Mare, Naida Faldetta, Chiara Modica, Giuseppe Pistone et al. · 2021 · Frontiers in Cell and Developmental Biology
12. Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications
    Binghao Zhao, Bo Chang Wu, Nan Feng, Xiang Zhang, Xin Zhang, Yiping Wei, Wenxiong Zhang · 2023 · Journal of Hematology & Oncology
13. Antiproliferative and pro-apoptotic effects of three fungal exocellular β-glucans in MCF-7 breast cancer cells is mediated by oxidative stress, AMP-activated protein kinase (AMPK) and the Forkhead transcription factor, FOXO3a
    Eveline Aparecida Isquierdo Fonseca de Queiroz, Zuleica Bruno Fortes, Mário Antônio Alves da Cunha, Aneli M. Barbosa, Neelam Khaper, Robert F. H. Dekker · 2015 · The International Journal of Biochemistry & Cell Biology
14. Cdk6-Dependent Regulation of G1 Length Controls Adult Neurogenesis
    Pierre Beukelaers, Renaud Vandenbosch, Nicolas Caron, Laurent Nguyen, Shibeshih Mitiku Belachew, Gustave Moonen, Hiroaki Kiyokawa, Mariano Barbacid, David Santamarı́a, Brigitte Malgrange · 2011 · Stem Cells
15. Silibinin Inhibits Proliferation, Induces Apoptosis and Causes Cell Cycle Arrest in Human Gastric Cancer MGC803 Cells Via STAT3 Pathway Inhibition
    Yixin Wang, Hong Cai, Gang Jiang, Tianbao Zhou, Hai Wu · 2014 · Asian Pacific Journal of Cancer Prevention
16. Tumour selective targeting of cell cycle kinases for cancer treatment
    Marieke Aarts, Spiros Linardopoulos, Nicholas C. Turner · 2013 · Current Opinion in Pharmacology
17. Atrazine exposure leads to altered growth of HepG2 cells
    Erin R. Powell, Noha Faldladdin, April D. Rand, Daniel Pelzer, Erin M. Schrunk, Kavita R. Dhanwada · 2011 · Toxicology in Vitro
18. Regulation of EMT by KLF4 in Gastrointestinal Cancer
    Jiujie Cui, Min Shi, Ming Quan, Keping Xie · 2013 · Current Cancer Drug Targets
19. Cyclin-Dependent Kinase 4–Mediated Phosphorylation Inhibits Smad3 Activity in Cyclin D–Overexpressing Breast Cancer Cells
    Stanislav Zelivianski, Anne E. Cooley, Ron Kall, Jacqueline Sara Jeruss · 2010 · Molecular Cancer Research
20. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway
    Xuechao Li, Yarong Song, Peng Zhang, Hongxue Zhu, Lifeng Chen, Yajun Xiao, Yifei Xing · 2015 · Tumor Biology
21. A new Prenylated Flavonoid induces G0/G1 arrest and apoptosis through p38/JNK MAPK pathways in Human Hepatocellular Carcinoma cells
    Di Wang, Qian Sun, Jie Wu, Wei Wang, Guo‐Dong Yao, Tianyang Li, Xue Li, Lingzhi Li, Yan Zhang, Wei Cui et al. · 2017 · Scientific Reports
22. Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis
    Guo Chen, Beilei Zhang, Haiyang Xu, Yao Sun, Y Shi, Yichen Luo, Haiying Jia, Fu Wang · 2017 · Oncogene
23. Galangin Induces Apoptosis in MCF-7 Human Breast Cancer Cells Through Mitochondrial Pathway and Phosphatidylinositol 3-Kinase/Akt Inhibition
    Dan Liu, Pengtao You, Yan Luo, Min Yang, Yanwen Liu · 2018 · Pharmacology
24. Cyclin‐dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer
    Jinglu Wang, Dylan C. Dean, Francis John Hornicek, Huirong Shi, Zhenfeng Duan · 2019 · The FASEB Journal
25. p53 and Cell Cycle Dependent Transcription of kinesin family member 23 (KIF23) Is Controlled Via a CHR Promoter Element Bound by DREAM and MMB Complexes
    Martin Fischer, Inga Grundke, Sindy Sohr, Marianne Quaas, Saskia Hoffmann, Arne Knörck, Catalina Gumhold, Karen Rother · 2013 · PLoS ONE
26. VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosis
    David S. Moura, Ignacio Campillo‐Marcos, Marta Vázquez-Cedeira, Pedro A. Lazo · 2018 · Cellular and Molecular Life Sciences
27. TRIM proteins in hepatocellular carcinoma
    Kan Lu, Yonglong Pan, Zhao Huang, Huifang Liang, Zeyang Ding, Bixiang Zhang · 2022 · Journal of Biomedical Science
28. Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future
    Rui Li, Miao Liu, Zhenya Yang, Jiao Li, Yuxin Gao, Ruirong Tan · 2022 · Molecules
29. Molecular mechanisms and anti‐cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines)
    Min Li‐Weber · 2014 · International Journal of Cancer
30. Epstein-Barr Virus BGLF4 Kinase Retards Cellular S-Phase Progression and Induces Chromosomal Abnormality
    Yu-Hsin Chang, Chung‐Pei Lee, Mei-Tzu Su, Jiin-Tarng Wang, Jen‐Yang Chen, Su‐Fang Lin, Ching-Hwa Ann Tsai, Min-Jei Hsieh, Kenzo Takada, Mei‐Ru Chen · 2012 · PLoS ONE
31. Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control
    Heidelinde Jäkel, Christina Weinl, Ludger Hengst · 2011 · Oncogene
32. Functional Reprogramming of Polyploidization in Megakaryocytes
    Marianna Trakala, Sara Rodríguez‐Acebes, María Maroto, Catherine E. Symonds, David Santamarı́a, Sagrario Ortega, Mariano Barbacid, Juan Méndez, Marcos Malumbres · 2015 · Developmental Cell
33. Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients – A study of the OVCAD consortium
    Dietmar Pils, Anna Bachmayr-Heyda, Katharina Auer, Martin Svoboda, Veronika Auner, Gudrun Hager, Eva Obermayr, Angelika Reiner, Alexander Reinthaller, Paul Speiser et al. · 2013 · European Journal of Cancer
34. MicroRNA-188 suppresses G 1 /S transition by targeting multiple cyclin/CDK complexes
    Jiangbin Wu, Qing Lv, Jie He, Haoxiang Zhang, Xueshuang Mei, Kai Cui, Nunu Huang, Weidong Xie, Naihan Xu, Yaou Zhang · 2014 · Cell Communication and Signaling
35. Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins
    Nana Zheng, Zhiwei Peter Wang, Wenyi Wei · 2016 · The International Journal of Biochemistry & Cell Biology
36. Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial
    Mónica Arnedos, Mohamed Amine Bayar, Bianca Cheaib, Véronique Scott, Ibrahim Bouakka, Alexander Valent, Julien Adam, Valerie Leroux-Kozal, Virginie Marty, Audrey Rapinat et al. · 2018 · Annals of Oncology
37. Haploinsufficient tumor suppressor genes.
    Kazushi Inoue, Elizabeth A. Fry · 2017 · PubMed
38. MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression
    Jianting Long, Caiwen Ou, Haoming Xia, Yifan Zhu, Dayue Liu · 2015 · Tumor Biology
39. Inhibition of E2F1 activity and cell cycle progression by arsenic via retinoblastoma protein
    Lynn A. Sheldon · 2017 · Cell Cycle
40. Karyopherin subunit-α 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma
    Chunlin Gao, Gao‐Wei Wang, Guan‐Qin Yang, Hong Yang, Li Zhuang · 2017 · Oncology Letters
41. Combination LSD1 and HOTAIR-EZH2 inhibition disrupts cell cycle processes and induces apoptosis in glioblastoma cells
    Jixing Zhao, Weili Jin, Kaikai Yi, Qixue Wang, Junhu Zhou, Yanli Tan, Can Xu, Menglin Xiao, Biao Hong, Fenfen Xu et al. · 2021 · Pharmacological Research
42. Targeting CDK4/6 in breast cancer
    Anusha Shanabag, Jessica Armand, Eugene Son, Hee Won Yang · 2025 · Experimental & Molecular Medicine
43. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma
    Weijia Liao, Guojin Huang, Yan Liao, Jianjun Yang, Qian Chen, Shengjun Xiao, Junfei Jin, Songqing He, Changming Wang · 2014 · Oncotarget
44. Downregulating hypoxia‐inducible factor‐2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma
    Changjun He, Xuepu Sun, Haiquan Qiao, Xian Jiang, Dongdong Wang, Xiangguo Jin, Xuesong Dong, Jizhou Wang, Hongchi Jiang, Xueying Sun · 2011 · Cancer Science
45. The expression of CDK1 is associated with proliferation and can be a prognostic factor in epithelial ovarian cancer
    Qinghua Xi, Menghui Huang, Yingying Wang, Jianxin Zhong, Rong Liu, Guiqin Xu, Lifei Jiang, Juan Wang, Zheng Fang, Shuyun Yang · 2015 · Tumor Biology
46. Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression
    LIN WANG, Guiying Wang, Dandan Yang, Xudong Guo, Yanxin Xu, Bo Feng, Jiuhong Kang · 2013 · Molecular Medicine Reports
47. An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing
    Yasuyuki Aoki, Rintaro Hashizume, Tomoko Ozawa, Anu Banerjee, Michael D. Prados, Charles David James, Nalin M. Gupta · 2012 · Journal of Neuro-Oncology
48. Kaempferol induces cell cycle arrest and apoptosis in renal cell carcinoma through EGFR/p38 signaling
    Wenbin Song, Qiang Dang, Defeng Xu, Yule Chen, Guodong Zhu, Kaijie Wu, Jin Zeng, Qingzhi Long, Xinyang Wang, Dalin He et al. · 2014 · Oncology Reports
49. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models
    Fuming Zi, Jing-Song He, Yi Li, Cai Wu, Li Yang, Yang Yang, Lijuan Wang, Dong-Hua He, Yi Zhao, Wen-Jun Wu et al. · 2014 · Cancer Letters
50. Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes
    Jincan Chen, Fa Peng, Yao Zhang, Baojun Li, Ji She, Xin-ming Jie, Zhilin Zou, Man Chen, Lanmei Chen · 2017 · European Journal of Medicinal Chemistry
51. Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta‐analysis
    Zuoyou Ding, Ran Li, Qijie Zhang, Yi Wang, Yi Jiang, Qing‐yang Meng, Qiulei Xi, Guo‐hao Wu · 2019 · Cancer Medicine
52. Two Distinct E2F Transcriptional Modules Drive Cell Cycles and Differentiation
    Maria C. Cuitiño, Thierry Pécot, Daokun Sun, Raleigh D. Kladney, Takayuki Okano‐Uchida, Neelam Shinde, Resham Saeed, Antonio Perez-Castro, Amy Webb, Tom Liu et al. · 2019 · Cell Reports
53. Development of covalent inhibitors: Principle, design, and application in cancer
    Zheng, Lang, Li, Yang, Wu, Defa, Xiao, Huan, Zheng, Shilong, Wang, Guan, Sun, Qiu · 2023 · MedComm – Oncology
54. Mechanistic selectivity investigation and 2D-QSAR study of some new antiproliferative pyrazoles and pyrazolopyridines as potential CDK2 inhibitors
    Ghaneya Sayed Hassan, Hanan Hanna Georgey, Esraa Z. Mohammed, Riham F. George, Walaa R. Mahmoud, Farghaly Abdelhamid Omar · 2021 · European Journal of Medicinal Chemistry
55. Role of Hypoxia in the Control of the Cell Cycle
    Jimena Druker, James W. Wilson, Fraser Child, Dilem Shakir, Temitope Fasanya, Sónia Rocha · 2021 · International Journal of Molecular Sciences
56. Health benefits of flaxseed and its peptides (linusorbs)
    Youn Young Shim, Ji Hye Kim, Jae Youl Cho, Martin J. T. Reaney · 2022 · Critical Reviews in Food Science and Nutrition
57. Cyclin-dependent Kinase-1 (Cdk1)/Cyclin B1 Dictates Cell Fate after Mitotic Arrest via Phosphoregulation of Antiapoptotic Bcl-2 Proteins
    Nandini Sakurikar, Joshua M. Eichhorn, Timothy C. Chambers · 2012 · Journal of Biological Chemistry
58. TIGAR induces p53-mediated cell-cycle arrest by regulation of RB–E2F1 complex
    Esha Madan, Rajan Gogna, Periannan Kuppusamy, Madan Lal Brahma Bhatt, Uttam Pati, Abbas Ali Mahdi · 2012 · British Journal of Cancer
59. miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2
    Xuesong Li, Xuhai Gong, Jing Chen, Jinghui Zhang, Jiahang Sun, Mian Guo · 2015 · Biochemical and Biophysical Research Communications
60. K+ channels and cell cycle progression in tumor cells
    Halima Ouadid‐Ahidouch, Ahmed Ahidouch · 2013 · Frontiers in Physiology
61. 6,7,4'-Trihydroxyisoflavone inhibits HCT-116 human colon cancer cell proliferation by targeting CDK1 and CDK2
    D. E. Lee, K. W. Lee, S. K. Jung, Eun Jig Lee, J. A. Hwang, T.-G. Lim, Bo Yeon Kim, Ann M. Bode, H. J. Lee, Ziming Dong · 2011 · Carcinogenesis
62. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies
    Muhammad Zaki Hidayatullah Fadlullah, Ivy Kim Chiang, Kalen R. Dionne, Pei San Yee, Chai Phei Gan, Kin Kit Sam, Kai Hung Tiong, Kwok Wen Ng, Daniel Martı́n, Kue Peng Lim et al. · 2016 · Oncotarget
63. Cell Cycle Regulation and Melanoma
    Wen Xu, Grant A. McArthur · 2016 · Current Oncology Reports
64. Chromosome territory relocation during DNA repair requires nuclear myosin 1 recruitment to chromatin mediated by ϒ-H2AX signaling
    Mugdha Kulashreshtha, Ishita S. Mehta, Pradeep Kumar, Basuthkar J. Rao · 2016 · Nucleic Acids Research
65. Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies
    Monica M Mita, Alain C. Mita, Jennifer L. Moseley, Jennifer Poon, Karen A. Small, Ying‐Ming Jou, Paul T. Kirschmeier, Da Zhang, Yali Zhu, Paul Statkevich et al. · 2017 · British Journal of Cancer
66. CDK1 dependent phosphorylation of hTERT contributes to cancer progression
    Mami Yasukawa, Yoshinari Ando, Taro Yamashita, Yoko Matsuda, Shisako Shoji, Masaki Suimye Morioka, Hideya Kawaji, Kumiko Shiozawa, Mitsuhiro Machitani, Takaya Abe et al. · 2020 · Nature Communications
67. P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy
    Diego M. Fernández‐Aroca, O. Roche, S. Sabater, Raquel Pascual‐Serra, Marta Ortega‐Muelas, Isabel Sánchez‐Pérez, Borja Belandia, María José Ruiz‐Hidalgo, Ricardo Sánchez‐Prieto · 2019 · Cancer Letters
68. Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
    Michela Cortesi, Michele Zanoni, Francesca Pirini, Maria Maddalena Tumedei, Sara Ravaioli, Ilario Giovanni Rapposelli, Giovanni Luca Frassineti, Sara Bravaccini · 2021 · International Journal of Molecular Sciences
69. Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer
    Xiuxiu Chen, Fengfeng Xie, Xiu-Jie Zhu, Feng Lin, Shi-Shi Pan, Li-Hua Gong, Jian-Ge Qiu, Wenji Zhang, Qiwei Jiang, Xiao-Long Mei et al. · 2015 · Oncotarget
70. The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition
    QING XIA, Yuchen Cai, Roujun Peng, Guosheng Wu, Yanxia Shi, Wenqi Jiang · 2013 · International Journal of Oncology
71. Optimization of 6,6-dimethyl pyrrolo[3,4-c]pyrazoles: Identification of PHA-793887, a potent CDK inhibitor suitable for intravenous dosing
    Maria Gabriella Brasca, Clara Albanese, Rachele Alzani, Raffaella Amici, Nilla Roberta Avanzi, Dario Ballinari, James Robert Bischoff, Daniela Borghi, Elena Casale, Valter Croci et al. · 2010 · Bioorganic & Medicinal Chemistry
72. StearoylCoA Desaturase-5: A Novel Regulator of Neuronal Cell Proliferation and Differentiation
    Debora I. Sinner, Gretchun J. Kim, Gregory C. Henderson, R. Ariel Igal · 2012 · PLoS ONE
73. An exploration of pathways involved in lung carcinoid progression using gene expression profiling
    Dorian R.A. Swarts, Leander Van Neste, Mieke E.R. Henfling, Ivo Eijkenboom, Paul P. Eijk, Marie‐Louise F. van Velthuysen, Aryan Vink, Marco Volante, Bauke Ylstra, Wim Van Criekinge et al. · 2013 · Carcinogenesis
74. Cellular senescence and protein degradation
    Xavier Deschênes‐Simard, Frédéric Lessard, Marie‐France Gaumont‐Leclerc, Nabeel M. Bardeesy, Gerardo Ferbeyre · 2014 · Cell Cycle
75. The Long Noncoding RNA LnRPT Is Regulated by PDGF-BB and Modulates the Proliferation of Pulmonary Artery Smooth Muscle Cells
    Jidong Chen, Jiao Guo, Xiaolei Cui, Yan Dai, Zhixiong Tang, Junle Qu, J. Usha Raj, Qinghua Hu, Deming Gou · 2017 · American Journal of Respiratory Cell and Molecular Biology
76. De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition
    Míriam Tarrado‐Castellarnau, Pedro de Atauri, Josep Tarragó‐Celada, Jordi Perarnau, Mariia O. Yuneva, Timothy M. Thomson, Marta Cascante · 2017 · Molecular Systems Biology
77. RETRACTED: YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway
    Dongfang Liu, Jingjing Zhang, Yang Feng Wu, Guodong Shi, Hao Yuan, Zipeng Lu, Qicong Zhu, Pengfei Wu, Cheng Lu, Feng Guo et al. · 2017 · International Journal of Cancer · Retracted
78. The acid-base transport proteins NHE1 and NBCn1 regulate cell cycle progression in human breast cancer cells
    Mette Flinck, Signe Hoejland Kramer, Julie Schnipper, Anne Poder Andersen, Stine F. Pedersen · 2018 · Cell Cycle
79. Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung Cancer
    Martin Reck, Leora Horn, Silvia Novello, Fabrice Barlési, István Albert, Erzsébet Juhász, Dariusz Mirosław Kowalski, G. Robinet, Jacques L. Cadranel, Paolo Bidoli et al. · 2019 · Journal of Thoracic Oncology
80. Role of cyclin‐dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathway
    Shen Shen, Dylan C. Dean, Zujiang Yu, Zhenfeng Duan · 2019 · Hepatology Research
81. Checking NEKs: Overcoming a Bottleneck in Human Diseases
    Andressa Peres de Oliveira, Luidy Kazuo Issayama, Isadora Carolina Betim Pavan, Fernando Riback Silva, Talita Diniz Melo‐Hanchuk, Fernando Moreira Simabuco, Jörg Kobarg · 2020 · Molecules
82. Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma
    Si‐Rui Ma, Soumon F. Rudra, Jian Li Campian, Sonika M Dahiya, Gavin P. Dunn, Tanner Michael Johanns, Michael Goldstein, Albert H. Kim, Jiayi Huang · 2020 · Neuro-Oncology Advances
83. CDK13 upregulation-induced formation of the positive feedback loop among circCDK13, miR-212-5p/miR-449a and E2F5 contributes to prostate carcinogenesis
    Jin‐Chun Qi, Zhan Yang, Tao Lin, Long Ma, Yaxuan Wang, Yong Zhang, Chun-Cheng Gao, Kai-Long Liu, Wei Li, An‐Ning Zhao et al. · 2021 · Journal of Experimental & Clinical Cancer Research
84. Novel Molecular Markers for Breast Cancer
    Kazushi Inoue, Elizabeth A. Fry · 2016 · Biomarkers in Cancer
85. DNA folds threaten genetic stability and can be leveraged for chemotherapy
    Joanna Zell, Francesco Rota Sperti, Sébastien Britton, David Monchaud · 2020 · RSC Chemical Biology
86. Recent advances in covalent organic frameworks for cancer diagnosis and therapy
    Ahmad Reza Bagheri, Chengjun Li, Xiaoli Zhang, Xiaoxia Zhou, Nahal Aramesh, Hongyu Zhou, Jianbo Jia · 2021 · Biomaterials Science
87. Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer
    James John Asciolla, Xuewei Wu, Christos Adamopoulos, Evripidis Gavathiotis, Poulikos I. Poulikakos · 2025 · Nature Cancer
88. Induction of p21Waf1/Cip1by Garcinol via Downregulation of p38-MAPK Signaling in p53-Independent H1299 Lung Cancer
    Sheng-Yung Yu, Chiung‐Ho Liao, Ming‐Hsien Chien, Tsung‐Yu Tsai, Jen-Kun Lin, Meng‐Shih Weng · 2014 · Journal of Agricultural and Food Chemistry
89. Dual cyclin‐dependent kinase 4/6 inhibition by PD‐0332991 induces apoptosis and senescence in oesophageal squamous cell carcinoma cells
    Liang Chen, Jingxuan Pan · 2017 · British Journal of Pharmacology
90. A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities
    Sabuj Kanti Das, Snehasis Mishra, Krishnendu Manna, Utpal Kayal, Supratim Mahapatra, Krishna Das Saha, Sasanka Dalapati, G. P. Das, Amany Mostafa, Asim Bhaumik · 2018 · Chemical Communications
91. Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family
    Paula Rodríguez‐Otero, José Román‐Gómez, Amaia Vilas‐Zornoza, Edurne San José‐Eneriz, Vanesa Martín‐Palanco, J. Rifón, António Torres, Marı́a José Calasanz, Xabier Agirre, Felipe Prósper · 2011 · British Journal of Haematology
92. Increased DKC1 expression in glioma and its significance in tumor cell proliferation, migration and invasion
    Faan Miao, Kun Chu, Hairong Chen, Meng Zhang, Pei-Cong Shi, Jin Bai, Yongping You · 2019 · Investigational New Drugs
93. Pectin coated nanostructured lipid carriers for targeted piperine delivery to hepatocellular carcinoma
    Eman M.M. Shehata, Mennatallah A. Gowayed, Samar O. El-Ganainy, Eman Sheta, Yosra S.R. Elnaggar, Ossama Y. Abdallah · 2022 · International Journal of Pharmaceutics
94. Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities
    Mitra Zabihi, Ramin Lotfi, Amir‐Mohammad Yousefi, Davood Bashash · 2022 · Journal of Cancer Research and Clinical Oncology
95. Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate‐specific antigen relapse time after radical prostatectomy
    Rie Amamoto, Mikako Yagi, YooHyun Song, Yoshinao Oda, Masazumi Tsuneyoshi, Seiji Naito, Akira Yokomizo, Kentaro Kuroiwa, Shoji Tokunaga, Seiji Kato et al. · 2010 · Cancer Science
96. Basic helix‐loop‐helix transcription factor DEC1 negatively regulates cyclin D1
    UJJAL KUMAR BHAWAL, Fuyuki Sato, Yuki Arakawa, Katsumi Fujimoto, Takeshi Kawamoto, Keiji Tanimoto, Yumi Ito, Tomonori Sasahira, Takashi Sakurai, Masaru Kobayashi et al. · 2011 · The Journal of Pathology
97. Mahanine, a novel mitochondrial complex-III inhibitor induces G0/G1 arrest through redox alteration-mediated DNA damage response and regresses glioblastoma multiforme.
    Kaushik Bhattacharya, Arup Kumar Bag, R. P. Tripathi, Suman Kumar Samanta, Bikas Chandra Pal, Chandrima Shaha, Chitra Mandal · 2014 · Europe PMC (PubMed Central)
98. Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs
    Diana D. Cirstea, Teru Hideshima, Loredana Santo, Homare Eda, Yuji Mishima, Neeharika Nemani, Yiguo Hu, Naoya Mimura, Francesca Cottini, Güllü Görgün et al. · 2013 · Leukemia
99. Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells
    Binoj Chandrasekharan Nair, Sreeram Vallabhaneni, RAJESHWAR RAO TEKMAL, Ratna K. Vadlamudi · 2011 · Breast Cancer Research
100. Anaphase Catastrophe Is a Target for Cancer Therapy
     Fabrizio Galimberti, Sarah L. Thompson, Saranya Ravi, Duane A. Compton, Ethan Dmitrovsky · 2011 · Clinical Cancer Research